Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board
W. Brian Dalton, Josh Lauring(Johnson & Johnson (United States)), Christopher D. Gocke, David M. Loeb(Albert Einstein College of Medicine), Eric S. Christenson(Johns Hopkins University), Vered Stearns(Johns Hopkins University), Patrick M. Forde(Sidney Kimmel Comprehensive Cancer Center), James R. Eshleman(Johns Hopkins University), Cindy Geoghegan, Hyunseok Kang(Johns Hopkins University), Dana Petry, Christine A. Pratilas(Johns Hopkins University), Jennifer Ensminger, Christian F. Meyer(Sidney Kimmel Comprehensive Cancer Center), Jennifer E. Axilbund(Johns Hopkins University), Heather A. Parsons(Harvard University), Ben Ho Park(Vanderbilt University Medical Center), Roisín M. Connolly(Johns Hopkins University), Shannon A. Slater(Parkland Health & Hospital System), Antonio C. Wolff(Johns Hopkins University)
Cited by 95
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
|Science|2006|3.2k